186 related articles for article (PubMed ID: 31069400)
21. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Percutaneous Thermal Ablation of Juxta-Cardiac Hepatic Tumours.
Kwan J; Appuhamy C; Lim GHT; Huang IKH; Quek L; Pua U
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):920-927. PubMed ID: 29582128
[TBL] [Abstract][Full Text] [Related]
23. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging.
Jiang C; Liu B; Chen S; Peng Z; Xie X; Kuang M
Int J Hyperthermia; 2018 Dec; 34(8):1135-1141. PubMed ID: 29392978
[TBL] [Abstract][Full Text] [Related]
24. Radiofrequency ablation using a multiple-electrode switching system for hepatocellular carcinoma within the Milan criteria: long-term results.
Tan Y; Jiang J; Wang Q; Guo S; Ma K; Bie P
Int J Hyperthermia; 2018 May; 34(3):298-305. PubMed ID: 28554226
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic radiofrequency ablation of subcapsular hepatocellular carcinomas: risk factors related to a technical failure.
Ko SE; Lee MW; Min JH; Ahn SH; Rhim H; Kang TW; Song KD; Kim JM; Choi GS; Cha DI; Lim HK
Surg Endosc; 2022 Jan; 36(1):504-514. PubMed ID: 33523278
[TBL] [Abstract][Full Text] [Related]
26. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
[TBL] [Abstract][Full Text] [Related]
28. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation.
Kim SS; Kang TW; Kim M; Lee MW; Cho SK; Paik YH; Kim MJ
Clin Radiol; 2018 Feb; 73(2):216.e1-216.e8. PubMed ID: 28859852
[TBL] [Abstract][Full Text] [Related]
29. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
30. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.
Chinnaratha MA; Sathananthan D; Pateria P; Tse E; MacQuillan G; Mosel L; Pathi R; Madigan D; Wigg AJ
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):349-54. PubMed ID: 25563141
[TBL] [Abstract][Full Text] [Related]
31. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression.
Liu CH; Arellano RS; Uppot RN; Samir AE; Gervais DA; Mueller PR
Eur Radiol; 2010 Apr; 20(4):877-85. PubMed ID: 19760232
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of percutaneous microwave ablation for hepatocellular carcinomas <4 cm in difficult location.
Mukund A; Ramalingam R; Anandpara KM; Patidar Y; Vijayaraghavan R; Sarin SK
Br J Radiol; 2020 Dec; 93(1116):20191025. PubMed ID: 32970472
[TBL] [Abstract][Full Text] [Related]
36. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation for 110 malignant liver tumours: preliminary results on percutaneous and surgical approaches.
Wong J; Lee KF; Lee PS; Ho SS; Yu SC; Ng WW; Cheung YS; Tsang YY; Ling E; Lai PB
Asian J Surg; 2009 Jan; 32(1):13-20. PubMed ID: 19321397
[TBL] [Abstract][Full Text] [Related]
38. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M
Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113
[TBL] [Abstract][Full Text] [Related]
39. [Radiofrequency ablation for liver tumour treatment].
Clemmesen TBR; Achiam MP; Pedersen CR; Larsen PN
Ugeskr Laeger; 2019 Sep; 181(36):. PubMed ID: 31538574
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous Dual-Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: A Preliminary Study.
Choi TW; Lee JM; Lee DH; Lee JH; Yu SJ; Kim YJ; Yoon JH; Han JK
Korean J Radiol; 2017; 18(5):799-808. PubMed ID: 28860897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
